Heiko Bruhn will be present at the @SachsAssociates 22nd Annual #Biotech in Europe Forum which will address the main challenges in investment, partnering and alliance management and prospects for 2023.
The programme
Day 1 (Wednesday, 21st of September)
- State of the Industry Panel
- VC & Private Equity Roundtable
- Advances in Platform Technologies & Novel Therapeutics Panel
- Investing in Gene & Cell Therapy Companies Panel
- Navigating Global Capital Markets in Current Times Panel
- Immuno-Oncology BD & Partnering Panel
- Immuno-Oncology Advanced Therapeutics Panel
- Latest Developments in Vaccines & Infectious Diseases Panel
Day 2 (Thursday, 22nd of September)
- China Strategies Panel
- Global Pharma-Biotech Partnering and M&A Roundtable
- CNS: Focus on Neurodegenerative Diseases Panel
- Innovation in UK Panel
- Therapeutic Session: Autoimmune & Inflammatory Diseases Panel
- Early Stage Investment Panel
- Rising Stars – Seed Companies Session
In-Person Meetings- 21st – 22nd of September
Virtual Meetings via Online Meeting System—26th – 30th of September
Networking Reception –21st of September